Heart failure & cardiomyopathies

Non-dilated left ventricular cardiomyopathy in patients with chronic Chagas disease and heart failure with reduced left ventricular ejection fraction

ESC Heart FailPublished Cohort of all patients with chronic Chagas disease (CChD) followed at our institution

Authors' conclusion

Non-dilated left ventricular cardiomyopathy affects one in 10 patients with CHF due to CChD, and the 5-year survival rate is 59%.

Study context

Population
Patients with chronic Chagas disease (CChD) and heart failure with reduced left ventricular ejection fractionpatients with CChD, 21 (10%) had non-dilated left ventricular cardiomyopathy (NDLVC)
Participants
215 patients
Exposure
NDLVC vs dilated cardiomyopathy (DCM) secondary to CChD
  • NDLVCn = 21
Outcome
Baseline characteristics of NDLVC group
Methodological detailssingle institution, January 2000 to January 2010
  • Single institution
  • January 2000 to January 2010

Main finding

As reported in the abstract

GroupMean ageMaleMedian daily dose of metoprololLeft ventricular diastolic diameter (LVDD)Left ventricular ejection fraction (LVEF)Segmental wall motion abnormalities (SWMA)
NDLVC62 ± 9 years12 (57%)100 (62, 5, 125) mg51 ± 29 mm39 ± 6.4%12 (57%)

NDLVC

Mean age62 ± 9 years
Male12 (57%)
Median daily dose of metoprolol100 (62, 5, 125) mg
Left ventricular diastolic diameter (LVDD)51 ± 29 mm
Left ventricular ejection fraction (LVEF)39 ± 6.4%
Segmental wall motion abnormalities (SWMA)12 (57%)

Observational data: associations, not effects.

Further findings

Predictor of all-cause mortality for patients with NDLVC (Cox regression)

Hazard ratio (95% CI)P value
Beta-blocker therapyOnly independent predictor0.16 (0.04–0.68)P = 0.01
OutcomeNDLVCDCMP value
Kaplan-Meier survival estimates at 12, 24, 36, 48, and 60 months · 60-month follow-up71%, 71%, 59%, 59%, and 59%77%, 61%, 49%, 38%, and 30%P = 0.04
All-cause mortality in NDLVC · Mean follow-up 50.8 ± 3.8 months
43% · 9 of 21

Original publication

Non-dilated left ventricular cardiomyopathy in patients with chronic Chagas disease and heart failure with reduced left ventricular ejection fraction. ESC Heart Fail. Published 13 January 2026. doi:10.1093/eschf/xvag020

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.